Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
| Status: | Completed |
|---|---|
| Conditions: | Ocular, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery, Ophthalmology |
| Healthy: | No |
| Age Range: | 14 - Any |
| Updated: | 10/14/2017 |
| Start Date: | December 2007 |
| End Date: | June 2010 |
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia or Progressive Keratoconus
Prospective, randomized, single site study to determine the safety and effectiveness of
performing corneal collagen cross-linking (CCCL)using riboflavin and UVA light in eyes with
corneal ectasia or progressive keratoconus.
performing corneal collagen cross-linking (CCCL)using riboflavin and UVA light in eyes with
corneal ectasia or progressive keratoconus.
Subjects are randomized to a control group or a treatment group, with the control group
crossed over to the treatment group at the 3 month visit. Corneal collagen cross-linking is
performed as a single treatment. Subjects are followed for at least 12 months to evaluate the
long term effects of corneal collagen cross-linking.
Subjects may be referred from other physicians but must return to Emory Vision for completion
of all study visits.
crossed over to the treatment group at the 3 month visit. Corneal collagen cross-linking is
performed as a single treatment. Subjects are followed for at least 12 months to evaluate the
long term effects of corneal collagen cross-linking.
Subjects may be referred from other physicians but must return to Emory Vision for completion
of all study visits.
Inclusion Criteria:
- Diagnosis of keratoconus with documented progression over the previous 12 months.
- Diagnosis of corneal ectasia
- Must be able to complete all study visits
Exclusion Criteria:
- Prior corneal surgery in the keratoconus group
- Corneal scarring
We found this trial at
1
site
Click here to add this to my saved trials
